BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Baumert TF, Thimme R, Weizsäcker FV. Pathogenesis of hepatitis B virus infection. World J Gastroenterol 2007; 13(1): 82-90 [PMID: 17206757 DOI: 10.3748/wjg.v13.i1.82]
URL: https://www.wjgnet.com/1007-9327/full/v13/i1/82.htm
Number Citing Articles
1
In Soo Oh, Su-Hyung Park. Immune-mediated Liver Injury in Hepatitis B Virus InfectionImmune Network 2015; 15(4): 191 doi: 10.4110/in.2015.15.4.191
2
Jing You, Hutcha Sriplung, Alan Geater, Virasakdi Chongsuvivatwong, Lin Zhuang, Hong-Ying Chen, Lan Yu, Bao-Zhang Tang, Jun-Hua Huang. Effect of viral load on T-lymphocyte failure in patients with chronic hepatitis BWorld Journal of Gastroenterology 2008; 14(7): 1112-1119 doi: 10.3748/wjg.14.1112
3
R. A. A. Pondé, D. D. P. Cardoso, M. O. Ferro. The underlying mechanisms for the ‘anti-HBc alone’ serological profileArchives of Virology 2010; 155(2): 149 doi: 10.1007/s00705-009-0559-6
4
Corinna M. Leistner, Stefanie Gruen-Bernhard, Dieter Glebe. Role of glycosaminoglycans for binding and infection of hepatitis B virusCellular Microbiology 2007; 0(0): 070810224957001 doi: 10.1111/j.1462-5822.2007.01023.x
5
Helen S. Te. Treatment of Acute Hepatitis B with Nucleoside and/or Nucleotide AnaloguesCurrent Hepatitis Reports 2010; 9(2): 119 doi: 10.1007/s11901-010-0033-7
6
Maimuna Mendy, Robert Walton. Molecular pathogenesis and early detection of hepatocellular carcinoma – Perspectives from West AfricaCancer Letters 2009; 286(1): 44 doi: 10.1016/j.canlet.2009.04.039
7
Ram Maya, M. Eric Gershwin, Yehuda Shoenfeld. Hepatitis B Virus (HBV) and Autoimmune DiseaseClinical Reviews in Allergy & Immunology 2008; 34(1): 85 doi: 10.1007/s12016-007-8013-6
8
Maria Nordin, Mikael Ingman, Beata Lindqvist, Karin Kidd-Ljunggren. Variability in the precore and core promoter region of the hepatitis B virus genomeJournal of Medical Virology 2014; 86(3): 437 doi: 10.1002/jmv.23839
9
Simone R.S. Conde, Rosimar N.M. Feitosa, Felipe Bonfim Freitas, Renata B. Hermes, Samia Demachki, Marialva T.F. Araújo, Manoel C.P. Soares, Ricardo Ishak, Antonio C.R. Vallinoto. Association of cytokine gene polymorphisms and serum concentrations with the outcome of chronic hepatitis BCytokine 2013; 61(3): 940 doi: 10.1016/j.cyto.2013.01.004
10
Jean Publicover, Amanda Goodsell, Stephen Nishimura, Silvia Vilarinho, Zhi-en Wang, Lia Avanesyan, Rosanne Spolski, Warren J. Leonard, Stewart Cooper, Jody L. Baron. IL-21 is pivotal in determining age-dependent effectiveness of immune responses in a mouse model of human hepatitis BJournal of Clinical Investigation 2011; 121(3): 1154 doi: 10.1172/JCI44198
11
Eduardo Asín-Prieto, Zinnia P. Parra-Guillen, José David Gómez Mantilla, Joris Vandenbossche, Kim Stuyckens, Xavier Woot de Trixhe, Juan José Perez-Ruixo, Iñaki F. Troconiz. A quantitative systems pharmacology model for acute viral hepatitis BComputational and Structural Biotechnology Journal 2021; 19: 4997 doi: 10.1016/j.csbj.2021.08.052
12
Jiajie Fang, Lu Zhuge, Heping Rao, Shanshan Huang, Lingxiang Jin, Jie Li. Increased Levels of miR-155 are Related to Higher T-Cell Activation in the Peripheral Blood of Patients with Chronic Hepatitis BGenetic Testing and Molecular Biomarkers 2019; 23(2): 118 doi: 10.1089/gtmb.2018.0092
13
Sarah De Baets, Kenny Roose, Bert Schepens, Xavier Saelens. Virus-like Particles in Vaccine Development2014; : 68 doi: 10.2217/fmeb2013.13.41
14
Suchithra Poilil Surendran, Reju George Thomas, Myeong Ju Moon, Rayoung Park, Doo Hyun Kim, Kyun Hwan Kim, Yong Yeon Jeong, Wenyu Lin. Effect of hepato-toxins in the acceleration of hepatic fibrosis in hepatitis B micePLOS ONE 2020; 15(5): e0232619 doi: 10.1371/journal.pone.0232619
15
Zi-Yi Huang, Ping Xu, Jian-Hua Li, Chen-Hua Zeng, Hua-Feng Song, Hui Chen, Yi-Bei Zhu, Ying-Ying Song, Han-Lin Lu, Chun-Ping Shen, Xue-Guang Zhang, Mei-Ying Wu, Xue-Feng Wang. Clinical Significance of Dynamics of Programmed Death Ligand-1 Expression on Circulating CD14+ Monocytes and CD19+ B Cells with the Progression of Hepatitis B Virus InfectionViral Immunology 2017; 30(3): 224 doi: 10.1089/vim.2016.0122
16
Michael Nassal. Hepatitis B viruses: Reverse transcription a different wayVirus Research 2008; 134(1-2): 235 doi: 10.1016/j.virusres.2007.12.024
17
Sun Young Lee, Kwang Hoon Song, Imhoi Koo, Kee-Ho Lee, Kyung-Suk Suh, Bu-Yeo Kim. Comparison of pathways associated with hepatitis B- and C-infected hepatocellular carcinoma using pathway-based class discrimination methodGenomics 2012; 99(6): 347 doi: 10.1016/j.ygeno.2012.04.004
18
Filipa Lebre, Gerrit Borchard, Maria Conceição Pedroso de Lima, Olga Borges. Progress Towards a Needle-Free Hepatitis B VaccinePharmaceutical Research 2011; 28(5): 986 doi: 10.1007/s11095-010-0314-4
19
Robério A. A. Pondé. Atypical serological profiles in hepatitis B virus infectionEuropean Journal of Clinical Microbiology & Infectious Diseases 2013; 32(4): 461 doi: 10.1007/s10096-012-1781-9
20
Sezin Asik Akman, Sukran Kose, Oya Halicioglu. Lamivudine and adefovir resistance in children and young adults with chronic hepatitis BInternational Journal of Infectious Diseases 2010; 14(3): e236 doi: 10.1016/j.ijid.2009.04.002
21
Ori Barzilai, Maya Ram, Yehuda Shoenfeld. Viral infection can induce the production of autoantibodiesCurrent Opinion in Rheumatology 2007; 19(6): 636 doi: 10.1097/BOR.0b013e3282f0ad25
22
Mousumi Khatun, Rajiv Kumar Mondal, Sourina Pal, Ayana Baidya, Debasree Bishnu, Priyanka Banerjee, Amal Kumar Santra, Gopal Krishna Dhali, Soma Banerjee, Abhijit Chowdhury, Simanti Datta. Distinctiveness in virological features and pathogenic potentials of subgenotypes D1, D2, D3 and D5 of Hepatitis B virusScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-26414-4
23
José M. Echevarría, Ana Avellón. Improved detection of natural hepatitis B virus surface antigen (HBsAg) mutants by a new version of the VITROS® HBsAg assayJournal of Medical Virology 2008; 80(4): 598 doi: 10.1002/jmv.21146
24
Helmut Denk. What is expected from the pathologist in the diagnosis of viral hepatitis?Virchows Archiv 2011; 458(4): 377 doi: 10.1007/s00428-011-1057-2
25
Kwesi Z Tandoh, Kwadwo A Kusi, Timothy N Archampong, Isaac Boamah, Osbourne Quaye. Hepatitis B infection outcome is associated with novel human leukocyte antigen variants in Ghanaian cohortExperimental Biology and Medicine 2020; 245(9): 815 doi: 10.1177/1535370220921118
26
Murat Karamese, Sabiha Aydogdu, Selina Aksak Karamese, Ulku Altoparlak, Cemal Gundogdu. Preventive Effects of a Major Component of Green Tea, Epigallocathechin-3-Gallate, on Hepatitis-B Virus DNA ReplicationAsian Pacific Journal of Cancer Prevention 2015; 16(10): 4199 doi: 10.7314/APJCP.2015.16.10.4199
27
Citrawati Dyah Kencono Wungu, Mochamad Amin, S. Eriaty N. Ruslan, Priyo Purwono, Ulfa Kholili, Ummi Maimunah, Poernomo Setiawan, Maria Lusida, Soetjipto Soetjipto, Retno Handajani. Association between host TNF‑α, TGF‑β1, p53 polymorphisms, HBV X gene mutation, HBV viral load and the progression of HBV‑associated chronic liver disease in Indonesian patientsBiomedical Reports 2019;  doi: 10.3892/br.2019.1239
28
Kenny Roose, Sarah De Baets, Bert Schepens, Xavier Saelens. Hepatitis B core–based virus–like particles to present heterologous epitopesExpert Review of Vaccines 2013; 12(2): 183 doi: 10.1586/erv.12.150
29
Michael Froelich, Robert W. Reid. Chestnut's Obstetric Anesthesia: Principles and Practice2009; : 1009 doi: 10.1016/B978-0-323-05541-3.00046-6
30
Rim Ouneissa, Olfa Bahri, Nissaf Ben Alaya-Bouafif, Sofiene Chouaieb, Ahlem Ben Yahia, Amel Sadraoui, Walid Hammami, Noureddine Filali, Mohamed Msaddak Azzouz, Nabyl Ben Mami, Henda Triki. Frequency and clinical significance of core promoter and precore region mutations in Tunisian patients infected chronically with hepatitis BJournal of Medical Virology 2012; 84(11): 1719 doi: 10.1002/jmv.23394
31
Patrizia Caligiuri, Rita Cerruti, Giancarlo Icardi, Bianca Bruzzone. Overview of hepatitis B virus mutations and their implications in the management of infectionWorld Journal of Gastroenterology 2016; 22(1): 145-154 doi: 10.3748/wjg.v22.i1.145
32
Walid Ben Selma, Ahmed Baligh Laribi, Sana Alibi, Jalel Boukadida. Association of an IFN-γ variant with susceptibility to chronic hepatitis B by the enhancement of HBV DNA replicationCytokine 2021; 143: 155525 doi: 10.1016/j.cyto.2021.155525
33
Fei Gao, Jun-Chi Xu, Li Zhu, Hui Chen, Xiao-Yan Zhu, Xin-Ran You, Shu-Xiang Li, Chen-Lu Zhu, Chen Yang, Chuan-Wu Zhu, Ping Xu. Clinical Significance of B7-H3 Expression During the Progression of Hepatitis B Virus InfectionViral Immunology 2018; 31(10): 668 doi: 10.1089/vim.2018.0102
34
Anyue Han, Lingna Li, Kuiyou Qing, Xiaolu Qi, Leping Hou, Xintong Luo, Shaohua Shi, Faqing Ye. Synthesis and biological evaluation of nucleoside analogues than contain silatrane on the basis of the structure of acyclovir (ACV) as novel inhibitors of hepatitis B virus (HBV)Bioorganic & Medicinal Chemistry Letters 2013; 23(5): 1310 doi: 10.1016/j.bmcl.2012.12.097
35
Xuefen Li, Yu Chen, Zhaowen Ma, Bo Ye, Wei Wu, Lanjuan Li. Effect of regulatory T cells and adherent cells on the expansion of HBcAg-specific CD8+ T cells in patients with chronic hepatitis B virus infectionCellular Immunology 2010; 264(1): 42 doi: 10.1016/j.cellimm.2010.04.009
36
Sirio Fiorino, Carmela Cursaro, Stefania Lorenzini, Elisabetta Loggi, Lucia Brodosi, Laura Cattani, Andrea Cuppini, Mauro Bernardi, Pietro Andreone. The pharmacology and activity of non-steroidal anti-inflammatory drugs (NSAIDs): a review of their use as an adjuvant treatment in patients with HBV and HCV chronic hepatitisItalian Journal of Medicine 2011; 5(2): 82 doi: 10.1016/j.itjm.2011.02.004
37
Jean-Pierre Allain, Ohene Opare-Sem. Screening and diagnosis of HBV in low-income and middle-income countriesNature Reviews Gastroenterology & Hepatology 2016; 13(11): 643 doi: 10.1038/nrgastro.2016.138
38
Protection status against hepatitis B infection assessed fromanti-HBs level, history of vaccination andhistory of infection based on anti-HBc in medical studentsIOP Conference Series: Earth and Environmental Science 2018; 125: 012104 doi: 10.1088/1755-1315/125/1/012104
39
Peiyuan Yin, Dafang Wan, Chunxia Zhao, Jing Chen, Xinjie Zhao, Wenzhao Wang, Xin Lu, Shengli Yang, Jianren Gu, Guowang Xu. A metabonomic study of hepatitis B-induced liver cirrhosis and hepatocellular carcinoma by using RP-LC and HILIC coupled with mass spectrometryMolecular BioSystems 2009; 5(8): 868 doi: 10.1039/b820224a
40
MENG ZHUO, LINLIN SONG, YUYAN TANG, SHENGLAN DAI, XIAOHUA CHEN, YONGSHENG YU, GUOQING ZANG, ZHENGHAO TANG. Vaccination with ubiquitin-hepatitis B core antigen-cytoplasmic transduction peptide enhances the hepatitis B virus-specific cytotoxic T-lymphocyte immune response and inhibits hepatitis B virus replication in transgenic miceMolecular Medicine Reports 2015; 12(3): 3591 doi: 10.3892/mmr.2015.3834
41
J. González-Gallego, M.J. Tuñón. Apoptosis: Involvement of Oxidative Stress and Intracellular Ca2+ Homeostasi2009; : 73 doi: 10.1007/978-1-4020-9873-4_4
42
Carmen Mirabelli, Matteo Surdo, Formijn Van Hemert, Zhichao Lian, Romina Salpini, Valeria Cento, Maria Francesca Cortese, Marianna Aragri, Michela Pollicita, Claudia Alteri, Ada Bertoli, Ben Berkhout, Valeria Micheli, Guido Gubertini, Maria Mercedes Santoro, Sara Romano, Michela Visca, Martina Bernassola, Roberta Longo, Giuseppe Maria De Sanctis, Pascal Trimoulet, Hervè Fleury, Nicoletta Marino, Francesco Mazzotta, Giuseppina Cappiello, Alberto Spanò, Cesare Sarrecchia, Jing Maria Zhang, Massimo Andreoni, Mario Angelico, Jens Verheyen, Carlo Federico Perno, Valentina Svicher. Specific mutations in the C-terminus domain of HBV surface antigen significantly correlate with low level of serum HBV-DNA in patients with chronic HBV infectionJournal of Infection 2015; 70(3): 288 doi: 10.1016/j.jinf.2014.10.015
43
Liyuan Tian, Yu Wang, Dabin Xu, Yanhong Gao, Xinyu Wen, Yaping Tian. The differential diagnostic model for serous peptidomics in HBV carriers established by MALDI-TOF-MS analysisClinical Biochemistry 2014; 47(1-2): 56 doi: 10.1016/j.clinbiochem.2013.10.016
44
Maisa M Ali, Fuad Hasan, Suhail Ahmad, Widad Al-Nakib. Comparative evaluation of INNO-LiPA HBV assay, direct DNA sequencing and subtractive PCR-RFLP for genotyping of clinical HBV isolatesVirology Journal 2010; 7(1) doi: 10.1186/1743-422X-7-111
45
Young-Joo Jin, Ju Hyun Shim, Young-Hwa Chung, Jeong A. Kim, Jong Gi Choi, Won Hyung Park, Danbi Lee, Yoon Seon Lee, Sung Eun Kim, Sung Hoon Kim, Soo Hyun Yang. Relationship of HLA-DRB1 Alleles With Hepatocellular Carcinoma Development in Chronic Hepatitis B PatientsJournal of Clinical Gastroenterology 2012; 46(5): 420 doi: 10.1097/MCG.0b013e318239f9cc
46
Zhikui Cheng, Ge Sun, Wei Guo, Yayun Huang, Weihua Sun, Fei Zhao, Kanghong Hu. Inhibition of hepatitis B virus replication by quercetin in human hepatoma cell linesVirologica Sinica 2015; 30(4): 261 doi: 10.1007/s12250-015-3584-5
47
V. E. Gurtsevitch. Human oncogenic viruses: Hepatitis B and hepatitis C viruses and their role in hepatocarcinogenesisBiochemistry (Moscow) 2008; 73(5): 504 doi: 10.1134/S0006297908050039
48
Arpit Bhargava, Saba Khan, Hariom Panwar, Neelam Pathak, Ram P. Punde, Subodh Varshney, Pradyumna K. Mishra. Occult hepatitis B virus infection with low viremia induces DNA damage, apoptosis and oxidative stress in peripheral blood lymphocytesVirus Research 2010; 153(1): 143 doi: 10.1016/j.virusres.2010.07.023
49
Neil D. Theise, Henry Charles Bodenheimer, Maria Guido. Macsween's Pathology of the Liver2018; : 372 doi: 10.1016/B978-0-7020-6697-9.00006-6
50
Peter Hafkemeyer, Ulrich Brinkmann, Elizabeth Brinkmann, Ira Pastan, Hubert E Blum, Thomas F Baumert. Pseudomonas exotoxin antisense RNA selectively kills hepatitis B virus infected cellsWorld Journal of Gastroenterology 2008; 14(18): 2810-2817 doi: 10.3748/wjg.14.2810
51
Application of k-means clustering algorithm in grouping the DNA sequences of hepatitis B virus (HBV)2017; 1862: 030134 doi: 10.1063/1.4991238
52
Yi-Hao Yen, Chao-Min Huang, Kuo-Liang Wei, Jing-Houng Wang, Sheng-Nan Lu, Chuan-Mo Lee, Chao-Hung Hung, Chien-Hung Chen, Po-Lin Tseng, Kuo-Chin Chang, Ming-Chao Tsai, Ming-Tsung Lin, Cheng-Kun Wu, Cheng-Hong Yang, Sin-Hua Moi, Chung-Lung Cho, Tsung-Hui Hu. MicroRNA-122 as a predictor of HBsAg seroclearance in hepatitis B and C dual infected patients treated with interferon and ribavirinScientific Reports 2016; 6(1) doi: 10.1038/srep33816
53
Neetu Rohit Kapoor, Vijay Kumar. Hepatitis B Virus: A Molecular PerspectiveProceedings of the National Academy of Sciences, India Section B: Biological Sciences 2012; 82(1): 31 doi: 10.1007/s40011-011-0003-z
54
Daniela C. Kroy, Georg M. Lauer, Kris Kowdley, Geoffrey McCaughan, Christian Trautwein. Hepatitis B virus infection: A strong case against ageismHepatology 2011; 54(4): 1477 doi: 10.1002/hep.24604
55
Jong Hun Kim, George Psevdos, Victoria Sharp. Five-Year Review of HIV-Hepatitis B Virus (HBV) Co-Infected Patients in a New York City AIDS CenterJournal of Korean Medical Science 2012; 27(7): 830 doi: 10.3346/jkms.2012.27.7.830
56
Yong-Wei Li, Feng-Cai Yang, Hui-Qiong Lu, Jiong-Shan Zhang. Hepatocellular carcinoma and hepatitis B surface proteinWorld Journal of Gastroenterology 2016; 22(6): 1943-1952 doi: 10.3748/wjg.v22.i6.1943
57
Marta Bes, Victor Vargas, Maria Piron, Natalia Casamitjana, Juan Ignacio Esteban, Nuria Vilanova, Asuncion Pinacho, Josep Quer, Lluis Puig, Jaime Guardia, Silvia Sauleda. T cell responses and viral variability in blood donation candidates with occult hepatitis B infectionJournal of Hepatology 2012; 56(4): 765 doi: 10.1016/j.jhep.2011.11.011
58
Rym Ayari, Yousr Lakhoua-Gorgi, Lamjed Bouslama, Imen Safar, Fatma Houissa Kchouk, Houda Aouadi, Saloua Jendoubi-Ayed, Taoufik Najjar, Kaled Ayed, Taieb Ben Abdallah. Investigation of DNA Sequence in the Basal Core Promoter, Precore, and Core Regions of Hepatitis B Virus from Tunisia Shows a Shift in Genotype PrevalenceHepatitis Monthly 2012; 12(11) doi: 10.5812/hepatmon.6191
59
Dinesh Mishra, Pradyumna Kumar Mishra, Sunil Dabadghao, Vaibhav Dubey, Manoj Nahar, Narendra K. Jain. Comparative evaluation of hepatitis B surface antigen–loaded elastic liposomes and ethosomes for human dendritic cell uptake and immune responseNanomedicine: Nanotechnology, Biology and Medicine 2010; 6(1): 110 doi: 10.1016/j.nano.2009.04.003
60
Evangelos Cholongitas, George V. Papatheodoridis, Emanuel K. Manesis, Kaliopi Petraki, Dina Tiniakos, Stephanos J. Hadziyannis. Effect of antiviral therapy on the immunohistochemical expression of bcl-xL and bax protein in patients with HBeAg-negative chronic hepatitis BJournal of Medical Virology 2011; 83(7): 1165 doi: 10.1002/jmv.21780
61
Ranjit Chauhan, Yoshimi Shimizu, Koichi Watashi, Takaji Wakita, Masayoshi Fukasawa, Tomasz I Michalak. Retrotransposon elements among initial sites of hepatitis B virus integration into human genome in the HepG2-NTCP cell infection modelCancer Genetics 2019; : 39 doi: 10.1016/j.cancergen.2019.04.060
62
Mayuko Nishi, Kei Miyakawa, Satoko Matsunaga, Hajera Khatun, Yutaro Yamaoka, Koichi Watashi, Masaya Sugiyama, Hirokazu Kimura, Takaji Wakita, Akihide Ryo. Prolyl Isomerase Pin1 Regulates the Stability of Hepatitis B Virus Core ProteinFrontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00026
63
Yi-Ling Wang, Gan-Guang Liou, Chao-Hsiung Lin, Mong-Liang Chen, Tzer-Min Kuo, Kuen-Nan Tsai, Chien-Choao Huang, Ya-Ling Chen, Li-Rung Huang, Yu-Chi Chou, Chungming Chang, Chiaho Shih. The Inhibitory Effect of the Hepatitis B Virus Singly-Spliced RNA-Encoded p21.5 Protein on HBV Nucleocapsid FormationPLOS ONE 2015; 10(3): e0119625 doi: 10.1371/journal.pone.0119625
64
Irina P Balmasova, Nikolay D Yushchuk, Ospan A Mynbaev, Nageswara R Alla, Elena S Malova, Zhongjie Shi, Chang-Lu Gao. Immunopathogenesis of chronic hepatitis BWorld Journal of Gastroenterology 2014; 20(39): 14156-14171 doi: 10.3748/wjg.v20.i39.14156
65
J.T. Gerlach, B. Müllhaupt. Akute VirushepatitidenDer Gastroenterologe 2007; 2(3): 186 doi: 10.1007/s11377-007-0085-6
66
Sarah Y. Neshat, Victor M. Quiroz, Yuanjia Wang, Sebastian Tamayo, Joshua C. Doloff. Liver Disease: Induction, Progression, Immunological Mechanisms, and Therapeutic InterventionsInternational Journal of Molecular Sciences 2021; 22(13): 6777 doi: 10.3390/ijms22136777
67
Nelson F Eng, Nitin Bhardwaj, Rebecca Mulligan, Francisco Diaz-Mitoma. The potential of 1018 ISS adjuvant in hepatitis B vaccinesHuman Vaccines & Immunotherapeutics 2013; 9(8): 1661 doi: 10.4161/hv.24715
68
Martin Potter, Marina B Klein. Co-infections and co-therapies: treatment of HIV in the presence of hepatitis C and hepatitis BHIV Therapy 2009; 3(2): 189 doi: 10.2217/17584310.3.2.189
69
Jing You, Lin Zhuang, Yi-Feng Zhang, Hong-Ying Chen, Hutcha Sriplung, Alan Geater, Virasakdi Chongsuvivatwong, Teerha Piratvisuth, Edward McNeil, Lan Yu, Bao-Zhang Tang, Jun-Hua Huang. Peripheral T-lymphocyte subpopulations in different clinical stages of chronic HBV infection correlate with HBV loadWorld Journal of Gastroenterology 2009; 15(27): 3382-3393 doi: 10.3748/wjg.15.3382
70
Takashi Hoshino, Hitoshi Takagi, Yuhei Suzuki, Atsushi Naganuma, Ken Sato, Satoru Kakizaki, Tsutomu Nishizawa, Hiroaki Okamoto, Masanobu Yamada. Fatal fulminant hepatitis caused by infection with subgenotype A1 hepatitis B virus with C1766T/T1768A core promoter mutationsClinical Journal of Gastroenterology 2016; 9(3): 160 doi: 10.1007/s12328-016-0649-4
71
Raimundas Razanskas, Kestutis Sasnauskas. Interaction of hepatitis B virus core protein with human GIPC1Archives of Virology 2010; 155(2): 247 doi: 10.1007/s00705-009-0561-z
72
Young-Joo Jin, Ju Hyun Shim, Young-Hwa Chung, Jeong A. Kim, Jong Gi Choi, Won Hyung Park, Danbi Lee, Sung Eun Kim, Yoon Seon Lee, Sung Hoon Kim, Soo Hyun Yang. HLA-DRB1*010101 Allele Is Closely Associated with Poor Virological Response to Lamivudine Therapy in Patients with Chronic Hepatitis BDigestion 2011; 84(s1): 35 doi: 10.1159/000333783
73
Amanda Abramson, Alan Menter, Robert Perrillo. Psoriasis, hepatitis B, and the tumor necrosis factor-alpha inhibitory agents: A review and recommendations for managementJournal of the American Academy of Dermatology 2012; 67(6): 1349 doi: 10.1016/j.jaad.2012.04.036
74
Jing You, Hutcha Sriplung, Alan Geater, Virasakdi Chongsuvivatwong, Lin Zhuang, Hong-Ying Chen, Jun-Hua Huang, Bao-Zhang Tang. Hepatitis B virus DNA is more powerful than HBeAg in predicting peripheral T-lymphocyte subpopulations in chronic HBV-infected individuals with normal liver function testsWorld Journal of Gastroenterology 2008; 14(23): 3710-3718 doi: 10.3748/wjg.14.3710
75
Thomas F Baumert, Eloi R Verrier, Michael Nassal, Raymond T Chung, Mirjam B Zeisel. Host-targeting agents for treatment of hepatitis B virus infectionCurrent Opinion in Virology 2015; 14: 41 doi: 10.1016/j.coviro.2015.07.009
76
Chang Bum Bae, Soon Sun Kim, Seun Joo Ahn, Hyo Jung Cho, Sei Rhan Kim, Sun Young Park, Ga Won Song, Dong Joon Kim, Seong Gyu Hwang, Jin Mo Yang, Young Bae Kim, Young Nyun Park, Sung Jae Shin, Sung Won Cho, Jae Youn Cheong. Caspase-cleaved fragments of cytokeratin-18 as a marker of inflammatory activity in chronic hepatitis B virus infectionJournal of Clinical Virology 2013; 58(4): 641 doi: 10.1016/j.jcv.2013.10.008
77
María Mercedes Elizalde, Ina Sevic, María Mora González López Ledesma, Rodolfo Héctor Campos, Luciana Barbini, Diego Martin Flichman. Human hepatocytes apoptosis induced by replication of hepatitis B virus subgenotypes F1b and F4: Role of basal core promoter and preCore mutationsVirology 2018; 513: 160 doi: 10.1016/j.virol.2017.10.016
78
Infectious Causes of Cancer2018; : 106 doi: 10.1002/9780470753651.ch7
79
Qiang Li, Furong Lu, Guohong Deng, Kaifa Wang. Modeling the effects of covalently closed circular DNA and dendritic cells in chronic HBV infectionJournal of Theoretical Biology 2014; 357: 1 doi: 10.1016/j.jtbi.2014.04.037
80
Jin-Lin Cheng, Hong Zhao, Shi-Gui Yang, Er-Mei Chen, Wen-Qian Chen, Lan-Juan Li. Plasma miRNA-122-5p and miRNA-151a-3p identified as potential biomarkers for liver injury among CHB patients with PNALTHepatology International 2018; 12(3): 277 doi: 10.1007/s12072-018-9871-0
81
J. Quer, M. Martell, F. Rodriguez, A. Bosch, R. Jardi, M. Buti, J.I. Esteban. Origin and Evolution of Viruses2008; : 303 doi: 10.1016/B978-0-12-374153-0.00015-1
82
Isaac Thom Shawa. Hepatitis B and C2020;  doi: 10.5772/intechopen.82772
83
E. Magiorkinis, D. Paraskevis, I.D. Pavlopoulou, M. Kantzanou, C. Haida, A. Hatzakis, I.N. Boletis. Renal transplantation from hepatitis B surface antigen (HBsAg)-positive donors to HBsAg-negative recipients: a case of post-transplant fulminant hepatitis associated with an extensively mutated hepatitis B virus strain and review of the current literatureTransplant Infectious Disease 2013; 15(4): 393 doi: 10.1111/tid.12094
84
O. Waidmann, V. Bihrer, T. Pleli, H. Farnik, A. Berger, S. Zeuzem, B. Kronenberger, A. Piiper. Serum microRNA-122 levels in different groups of patients with chronic hepatitis B virus infectionJournal of Viral Hepatitis 2012; 19(2): e58 doi: 10.1111/j.1365-2893.2011.01536.x
85
Jing You, Hutcha Sriplung, Alan Geater, Virasakdi Chongsuvivatwong, Lin Zhuang, Yun-Li Li, Hua Lei, Jun Liu, Hong-Ying Chen, Bao-Zhang Tang, Jun-Hua Huang. Impact of viral replication inhibition by entecavir on peripheral T lymphocyte subpopulations in chronic hepatitis B patientsBMC Infectious Diseases 2008; 8(1) doi: 10.1186/1471-2334-8-123
86
Junyan Feng, Lu Lu, Cong Hua, Ling Qin, Pingwei Zhao, Juan Wang, Ye Wang, Wanyu Li, Xiaodong Shi, Yanfang Jiang, Clive M. Gray. High Frequency of CD4+CXCR5+ TFH Cells in Patients with Immune-Active Chronic Hepatitis BPLoS ONE 2011; 6(7): e21698 doi: 10.1371/journal.pone.0021698
87
Subuhi Sherwani, Mushtaq Ahmed Khan, Mohammed Suliman Almogbel. Autoantibodies and Cytokines2019;  doi: 10.5772/intechopen.80471
88
Yen-Cheng Lin, En-Chi Hsu, Ling-Pai Ting. Repression of hepatitis B viral gene expression by transcription factor nuclear factor-kappaBCellular Microbiology 2009; 11(4): 645 doi: 10.1111/j.1462-5822.2008.01280.x
89
Molecular Microbiology2016; : 256 doi: 10.1128/9781555819071.ch21
90
Yong Huang, Haijun Deng, Zhi Peng, Yao Huang, Quanxin Long, Ailong Huang. Mutations of Basal Core Promoter and Precore Regions in Hepatitis B Virus Genotypes B and CHepatitis Monthly 2014; 15(1) doi: 10.5812/hepatmon.23034